N/A N=25 PMCF Study on CranioFix®2 System Used for the Fixation of Craniotomized Bone Flaps and Fractures
Skull Fractures
Primary: Planarity of Bone Flap After Implantation — 23; 0; 2; 17 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=1,492 ASSIST Registry Studying Various Operator Techniques
Ischemic Stroke
Primary: Percentage of Subjects Achieved Good Functional Outcome (mRS 0-2) at Day 90 — 140; 351; 273 Participants
N/A N=323 Stress, Salt Excretion, and Nighttime Blood Pressure
Blood Pressure · Psychological Stress
Primary: Ratio of Awake-to-asleep Urinary Sodium Excretion Rate (Aim 1) — 1.4 Ratio of awake-to-asleep — p=0.0032
Phase 2 N=35 De-Escalation Therapy for Human Papillomavirus Negative Disease
Human Papilloma Virus · Squamous Cell Carcinoma · Squamous Cell Carcinoma of the Head and Neck
Primary: Deep Response Rate (DRR) — 16; 19 Participants
N/A N=120 A Physical Therapist Administered Physical Activity Intervention After Total Knee Replacement
Physical Activity
Primary: Physical Activity Measured by an Actigraph GT3X Monitor — 9.8; 23.8; 63; 86.8 Minutes/Week
N/A N=9 Virtual Reality and Meditation for Fibromyalgia
Fibromyalgia
Primary: Pain Numerical Rating Scale [NRS] (Change From Pre-intervention to Post-intervention) — 4.4; 4.8 score on a scale
N/A N=427 PiPT in ADSM With MSD
Chronic Pain · Musculoskeletal Diseases or Conditions
Primary: Change in Pain Disability Index (PDI) Score — 0; 33 Change in PDI score
Phase 2 N=60 Evaluating the Role of Neuroinflammation in Low Back Pain
Low Back Pain · Back Pain With Radiation · Back Pain Without Radiation
Primary: Changes in Thalamic Standardized Uptake Value Ratio (SUVR) — 1.188; 1.166; 1.189; 1.165 Standardized uptake value ratio — p=0.956
N/A N=22 Comparing of the Clinical Outcome of Periodontal Accelerated Osteogenic Orthodontics With Horizontal or Vertical Releasing Incisions
Malocclusion
Primary: Surgery Time — 57.66; 68.50 minutes
N/A N=951 OraQuick® HIV Self-Test Study in Canada
HIV Testing · HIV Infections
Primary: Device Performance: Positive and Negative Percent Agreement — 1; 0; 880; 0 Participants
N/A N=2 Moisture Management Liner Effectiveness Study
Amputation Stumps · Amputees · Amputation
Primary: Residual Limb Temperature — 3.0; 3.2 Degrees Fahrenheit
Phase 3 N=141 Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor
Neuroendocrine Tumors
Primary: First Progression Free Survival (PFS1) — 71.4; 61.8 percentage of patients alive and PD-free — p=0.229
Phase 4 N=84 Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery
Kidney Transplant; Complications · Postoperative Residual Curarization · Postoperative Residual Weakness
Primary: Number of Patients With Hypoventilation in Post-anesthesia Care Unit (PACU) — 22; 23 Participants
N/A N=131 ATP Level and Cough Sensitivity to ATP in Subjects With Refractory/Unexplained Chronic Cough
Refractory/Unexplained Chronic Cough
Primary: ATP Level in Sputum Supernatant — 2313.4; 1804.6 pM
N/A N=28 An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System In Pseudophakic Eyes With Primary Open Angle Glaucoma (ORION 2.0)
Glaucoma, Open-Angle
Primary: Change in Intraocular Pressure (IOP) — 38.2; 30.1 percent change